{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/03/3306039/0/en/LIXTE-Biotechnology-Announces-16-566-027-Registered-Direct-Offering-Priced-at-the-Market-Under-Nasdaq-Rules-Strengthening-Balance-Sheet-for-Next-Phase-of-Strategic-Growth.html", "message": "News view counter 777239 successfully enlarged"}